Full Text:   <1236>

Summary:  <0>

CLC number: 

On-line Access: 2020-03-01

Received: 2019-10-18

Revision Accepted: 2020-01-22

Crosschecked: 2020-03-01

Cited: 0

Clicked: 1574

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
Open peer comments

Bio-Design and Manufacturing  2020 Vol.3 No.1 P.7-14

http://doi.org/10.1007/s42242-020-00060-0


Design andstrategy formanufacturing kidney organoids


Author(s):  MasakiNishikawa, YasuyukiSakai, NorimotoYanagawa

Affiliation(s):  Department ofChemical System Engineering, School ofEngineering, University ofTokyo, Rm. 5A01, Engineering Bldg. 3, Hongo 7-3-1, Bunkyo, Tokyo113-8656, Japan; more

Corresponding email(s):   masaki@chemsys.t.u-tokyo.ac.jp

Key Words:  Kidney organoid, Kidney development, iPSC, Progenitor cell, Self-organization, Regenerative medicine


Share this article to: More

MasakiNishikawa, YasuyukiSakai, NorimotoYanagawa. Design andstrategy formanufacturing kidney organoids[J]. Journal of Zhejiang University Science D, 2020, 3(1): 7-14.

@article{title="Design andstrategy formanufacturing kidney organoids",
author="MasakiNishikawa, YasuyukiSakai, NorimotoYanagawa",
journal="Journal of Zhejiang University Science D",
volume="3",
number="1",
pages="7-14",
year="2020",
publisher="Zhejiang University Press & Springer",
doi="10.1007/s42242-020-00060-0"
}

%0 Journal Article
%T Design andstrategy formanufacturing kidney organoids
%A MasakiNishikawa
%A YasuyukiSakai
%A NorimotoYanagawa
%J Journal of Zhejiang University SCIENCE D
%V 3
%N 1
%P 7-14
%@ 1869-1951
%D 2020
%I Zhejiang University Press & Springer
%DOI 10.1007/s42242-020-00060-0

TY - JOUR
T1 - Design andstrategy formanufacturing kidney organoids
A1 - MasakiNishikawa
A1 - YasuyukiSakai
A1 - NorimotoYanagawa
J0 - Journal of Zhejiang University Science D
VL - 3
IS - 1
SP - 7
EP - 14
%@ 1869-1951
Y1 - 2020
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1007/s42242-020-00060-0


Abstract: 
Despite a continuing increase in the number of patients sufering from chronic kidney disease, currently available treatments for these patients, such as dialysis and kidney transplantation, are imperfect. The kidney is also a critical target organ vulnerable to the toxicity of various new drugs, and the lack of a reliable invitro culture model imposes a severe limitation on drug discovery. Although the development of induced pluripotent stem cells (iPSCs) revolutionized strategies in biomedical felds, the complexity of the kidney imposed additional challenge to the application of this technology in kidney regeneration. Nonetheless, the recent advancement in our understanding on the developmental origin of kidney progenitor cells and the mechanisms of their reciprocal induction and self-organization has boosted research in kidney regeneration. Research since then has demonstrated that kidney organoids derived from iPSCs can serve as a useful model for drug discovery and toxicity screening, as well as for disease modeling, especially in combination with gene editing techniques. Moreover, attempts at kidney organoid implantation in animals have suggested their potential as an alternative source of kidney transplantation. In this review, we summarize recent progress on the generation of kidney organoids, as well as the obstacles that remain.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2022 Journal of Zhejiang University-SCIENCE